4.6 Article

Expression of TCF7L2 in Glioma and Its Relationship With Clinicopathological Characteristics and Patient Overall Survival

Related references

Note: Only part of the references are listed.
Review Oncology

MGMT Status as a Clinical Biomarker in Glioblastoma

Madison Butler et al.

TRENDS IN CANCER (2020)

Article Biochemistry & Molecular Biology

TCF7L2 gene polymorphisms and susceptibility to breast cancer: a meta-analysis

X. P. Lu et al.

GENETICS AND MOLECULAR RESEARCH (2015)

Article Multidisciplinary Sciences

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

Stefani Spranger et al.

NATURE (2015)

Article Multidisciplinary Sciences

Comprehensive molecular characterization of human colon and rectal cancer

Donna M. Muzny et al.

NATURE (2012)

Article Multidisciplinary Sciences

T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis

Melinda L. Angus-Hill et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Oncology

Prognostic factors for survival in adult patients with cerebral low-grade glioma

F Pignatti et al.

JOURNAL OF CLINICAL ONCOLOGY (2002)